Italian Pharmacological Agency Warns Against The Use Of Hydroxychloroquine

A bottle and pills of Hydroxychloroquine sit on a counter at Rock Canyon Pharmacy in Provo, Utah, on May 20, 2020. - US President Donald Trump announced May 18 he has been taking hydroxychloroquine for almost two wee... A bottle and pills of Hydroxychloroquine sit on a counter at Rock Canyon Pharmacy in Provo, Utah, on May 20, 2020. - US President Donald Trump announced May 18 he has been taking hydroxychloroquine for almost two weeks as a preventative measure against COVID-19. (Photo by GEORGE FREY / AFP) (Photo by GEORGE FREY/AFP via Getty Images) MORE LESS
|
May 22, 2020 9:17 a.m.

ROME — The head of Italy’s pharmacological agency says there is little data about the effectiveness of the anti-malaria drug promoted by U.S. President Donald Trump to treat coronavirus.

Dr. Nicola Magrini offered a briefing on the various trials the Italian Pharmacological Agency had approved during the coronavirus crisis, including one involving hydroxychloroquine.

Magrini says while the drug was being used in Italy, the agency recommended it only in some patients, preferably on its own or in association with other drugs only in clinical trial settings.

While the science is still out on hydroxychloroquine’s effectiveness, Magrini said: “We are fairly certain about the possible harm and absence of security of using it in some limited sub-groups of patients.”

Trump has said he is taking hydroxychloroquine to protect against the coronavirus, even though his administration has warned it can have deadly side effects.

Magrini adds he didn’t expect a vaccine before spring or summer of next year. Italian researchers are collaborating on the Oxford University vaccine.

Latest News
Comments
advertisement
Masthead Masthead
Founder & Editor-in-Chief:
Executive Editor:
Managing Editor:
Senior Editor:
Special Projects Editor:
Editor at Large:
General Counsel:
Publisher:
Head of Product:
Director of Technology:
Associate Publisher:
Front-End Developer:
Senior Designer:
SPECIAL DEAL FOR PAST TPM MEMBERS
40% OFF AN ANNUAL PRIME MEMBERSHIP
REJOIN FOR JUST $30